IIT-Guwahati to offer 4-year BS program in Biomedical Science and Engineering, no JEE score needed

Prof Devendra Jalihal, director, IIT Guwahati, said, “This interdisciplinary program brings together engineering, medical sciences, and pharmacology on a single platform, addressing the need for professionals who can work across disciplines to tackle future challenges. As the problems of tomorrow will not fit into traditional silos, this program is designed to bridge those gaps. Supported by the Mehta Family Foundation and reviewed by leading experts from IIT Guwahati, AIIMS Guwahati and NIPER Guwahati, it is set to be a pioneering initiative. We are confident that this program will foster the next generation of biomedical engineers, preparing them to innovate and lead in healthcare and pharmaceutical industries.”

The application process for the program will begin on April 25- May 25, 2025. Interested candidates are encouraged to visit the official website and submit their applications.

Prof Ashok Puranik, Director, AIIMS Guwahati, said, “This multi-institutional collaboration is a landmark initiative that will shape the future of healthcare and education in India. With this initiative, we aim to bridge the gap between engineering, biotechnology, and medicine. With advancements in genomics, Artificial Intelligence, 3D printing, and nanotechnology, it empowers the next generation of biomedical innovators. By combining the strengths of AIIMS Guwahati, IIT Guwahati, and NIPER Guwahati, we are creating an ecosystem that will drive the future of healthcare and medical technology in India.”

The program will offer a strong academic foundation with comprehensive coursework spanning pre-clinical, para-clinical, and clinical domains. Students will gain hands-on skill development through specialised engineering modules designed to bridge the gap between technology and healthcare.

A key highlight of the program is its clinical immersion component, which allows students to work closely with renowned surgeons and healthcare professionals, gaining valuable hands-on experience. In addition, the curriculum features a cross-institutional learning approach through collaborations with AIIMS Guwahati and NIPER Guwahati, ensuring that students are exposed to a wide range of insights and methodologies in the fields of biomedical science and engineering.

Emphasising the significance of the program and its unique interdisciplinary approach, Rahul Mehta, CEO, the Mehta Family Foundation, said, “This program represents a thoughtful step forward at the intersection of healthcare and engineering, two domains that will shape the future of India. What makes it truly special is the collaboration between IIT Guwahati, AIIMS Guwahati, and NIPER Guwahati, bringing together doctors, scientists, and engineers under one academic vision. For students passionate about both mathematics and biology, this program will enable them to innovate in areas such as medical devices, drug discovery, and more.”

Eligibility criteria

The program is open to students who appeared for Class 12 (or equivalent) in 2024 or 2025 with Physics, Chemistry, Mathematics, and Biology, and have secured a minimum of 75% aggregate marks in these subjects. Moreover, students who have qualified the IISER Aptitude Test 2025 are eligible to apply.

New programme offers advanced topics

The program curriculum is designed to be multidisciplinary and future-focused, encompassing a wide range of subjects including Mechanics, Electrical and Electronic Systems, Mathematical modelling, Design and Prototyping, and Bioinformatics. . In addition to this, students will also engage with advanced topics such as:

· Biomedical devices

· Pharmacology

· Informatics and AI in medicine

· Bioinstrumentation

· Sensors and wearable devices

From a career perspective, graduates of the program will find opportunities across a wide range of domains, including bioinstrumentation, biomedical devices, pharmacology and therapeutics, bioinformatics, and artificial intelligence, as well as research and development in health technology.